Compare
Pyxus International, Inc. vs Andersons, Inc. vs CHS Inc
| Latest fiscal year | Pyxus International, Inc. PYYX | Andersons, Inc. ANDE | CHS Inc CHSCL |
|---|---|---|---|
| Year ended | 2026-03-31 | 2025-12-31 | 2026-08-31 |
| Revenue | $2.41B | $11.01B | $39.23B |
| Revenue growth (YoY) | -2.8% | -2.2% | +10.6% |
| Gross margin | 14.4% | 6.5% | 4.6% |
| Operating margin | 6.7% | n/a | 1.5% |
| Net margin | 0.6% | 0.9% | 2.8% |
| Net income | $14.57M | $95.71M | $1.10B |
| EPS (Diluted) | $0.56 | n/a | n/a |
| Operating cash flow | -$208.45M | $177.00M | $1.58B |
| Free cash flow | -$230.50M | -$56.12M | $1.12B |
| Cash & equivalents | $134.34M | $98.28M | $263.60M |
| Total assets | $1.69B | $3.71B | $20.11B |
| Total liabilities | $1.51B | $2.42B | n/a |
| Shareholders' equity | $181.11M | $1.29B | $11.64B |
| Return on year-end equity | 8.0% | 7.4% | 9.4% |
| Shares outstanding | 24.61M | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Pyxus International, Inc. | Andersons, Inc. | CHS Inc |
|---|---|---|---|
| Latest | $2.41B Ended 2026-03-31 | $11.01B Ended 2025-12-31 | $39.23B Ended 2026-08-31 |
| 1 year earlier | $2.48B Ended 2025-03-31 | $11.26B Ended 2024-12-31 | $35.46B Ended 2025-08-31 |
| 2 years earlier | $2.03B Ended 2024-03-31 | $14.75B Ended 2023-12-31 | $39.26B Ended 2024-08-31 |
| 3 years earlier | $1.91B Ended 2023-03-31 | $17.33B Ended 2022-12-31 | $45.59B Ended 2023-08-31 |
| 4 years earlier | $1.64B Ended 2022-03-31 | $12.61B Ended 2021-12-31 | $47.79B Ended 2022-08-31 |